Ending the Prescribe-Don’t-Tell Charade for Off-Label Drugs

The Wall Street Journal

Ending the Prescribe-Don’t-Tell Charade for Off-Label Drugs

Cahill litigators prevailed on behalf of drug-maker Amarin Pharma Inc. in a ground breaking challenge to the constitutionality of FDA restrictions of off label promotion of approved prescription drugs.

Cahill’s high profile victory for Amarin in this closely watched case garnered top awards in the legal industry in 2016, including Cahill being named among North America’s most innovative law firms by Financial Times, and the lead partners being named “Litigators of the Week” by American Lawyer magazine and to the National Law Journal’s “Litigation Trailblazers” list.